About KELI Therapeutics
KELI Therapeutics is a clinical-stage biotech university spin-out company specializing in cell-based therapeutics. ๐ผ Seeking Visionary Investors: We are currently raising 5 Mio EUR (24 months of the runway) to accelerate our lead program, KELI-101, in a First-In-Human, multi-center, adaptive Ph1/2A-B clinical trial (24 months) ๐ฑ Pioneering Allogeneic GMP-grade Placental Stem Cells: Backed by non-dilutive funding, our proprietary platform has undergone rigorous validation in four non-clinical animal studies, setting new benchmarks for therapeutic potential. ๐งช Expert Team of Biotech Innovators: Our interdisciplinary team boasts top-tier drug developers, regulatory experts, biotechnologists, and physicians, united in delivering groundbreaking medical breakthroughs. ๐ก Scalable Manufacturing Excellence: Our placental stromal cell-based 2D/3D manufacturing platform ensures streamlined production of an extensive pipeline of advanced therapeutic medicinal products. โ๏ธ Quality Control at the Core: Focusing on rigorous quality control measures, we underscore the safety and efficacy of our innovative therapeutic solutions. ๐ผ Collaborate for Success: Seeking partnerships with like-minded investors and biotech pioneers to drive healthcare innovation forward. ๐ฐ Investment Opportunities: Join our transformative journey and explore potential significant returns on investment in the rapidly evolving biotech landscape. ๐ Global Impact, Local Focus: Embrace the future of medicine as we bridge the gap between scientific advancements and patient-centric solutions with a global reach.
- Employees
- 11 to 50
- Headquarters
- Lithuania
Leadership
The top of KELI Therapeutics's org chart, with how many people report into each leader.
Justinas Maciulaitis
Founder and CEO
Jobs at KELI Therapeutics
No open positions right now. Explore more companies on TheJobsMap.